Dallah Healthcare Company (4004.SR)
SAR 157.6
(0.38%)
SAR 157.6
(0.38%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.73 Billion SAR | -0.08% |
| 2022 | 1.73 Billion SAR | 3.47% |
| 2021 | 1.68 Billion SAR | 20.17% |
| 2020 | 1.39 Billion SAR | 47.0% |
| 2019 | 951.69 Million SAR | 43.75% |
| 2018 | 662.03 Million SAR | 39.85% |
| 2017 | 473.39 Million SAR | 60.57% |
| 2016 | 294.81 Million SAR | -1.69% |
| 2015 | 299.89 Million SAR | 128.02% |
| 2014 | 131.52 Million SAR | 85.31% |
| 2013 | 70.97 Million SAR | 112.78% |
| 2012 | -555.44 Million SAR | -14477.84% |
| 2011 | -3.81 Million SAR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.75 Billion SAR | 2.96% |
| 2024 Q1 | 1.7 Billion SAR | -1.83% |
| 2023 Q4 | 1.73 Billion SAR | -0.73% |
| 2023 FY | 1.73 Billion SAR | -0.08% |
| 2023 Q3 | 1.75 Billion SAR | 4.37% |
| 2023 Q1 | 1.76 Billion SAR | 1.35% |
| 2023 Q2 | 1.67 Billion SAR | -4.85% |
| 2022 Q4 | 1.73 Billion SAR | 3.82% |
| 2022 Q1 | 1.72 Billion SAR | 2.77% |
| 2022 Q3 | 1.67 Billion SAR | -0.73% |
| 2022 FY | 1.73 Billion SAR | 3.47% |
| 2022 Q2 | 1.68 Billion SAR | -2.31% |
| 2021 Q3 | 1.32 Billion SAR | 3.32% |
| 2021 Q1 | 1.36 Billion SAR | -2.29% |
| 2021 FY | 1.68 Billion SAR | 20.17% |
| 2021 Q2 | 1.28 Billion SAR | -5.89% |
| 2021 Q4 | 1.68 Billion SAR | 26.49% |
| 2020 Q1 | 986.45 Million SAR | 3.65% |
| 2020 Q2 | 1.04 Billion SAR | 6.32% |
| 2020 Q3 | 1.03 Billion SAR | -1.68% |
| 2020 FY | 1.39 Billion SAR | 47.0% |
| 2020 Q4 | 1.39 Billion SAR | 35.67% |
| 2019 Q2 | 953.93 Million SAR | 29.46% |
| 2019 FY | 951.69 Million SAR | 43.75% |
| 2019 Q4 | 951.69 Million SAR | -0.23% |
| 2019 Q3 | 953.9 Million SAR | -0.0% |
| 2019 Q1 | 736.83 Million SAR | 11.3% |
| 2018 Q1 | 443.7 Million SAR | -6.27% |
| 2018 FY | 662.03 Million SAR | 39.85% |
| 2018 Q4 | 662.03 Million SAR | -3.25% |
| 2018 Q3 | 684.24 Million SAR | 6.7% |
| 2018 Q2 | 641.26 Million SAR | 44.53% |
| 2017 Q3 | 410.12 Million SAR | 2.96% |
| 2017 Q1 | 266.36 Million SAR | -9.65% |
| 2017 Q4 | 473.39 Million SAR | 15.43% |
| 2017 FY | 473.39 Million SAR | 60.57% |
| 2017 Q2 | 398.34 Million SAR | 49.55% |
| 2016 Q3 | 411.23 Million SAR | 9.69% |
| 2016 FY | 294.81 Million SAR | -1.69% |
| 2016 Q2 | 374.9 Million SAR | 28.24% |
| 2016 Q1 | 292.34 Million SAR | -2.52% |
| 2016 Q4 | 294.81 Million SAR | -28.31% |
| 2015 Q3 | 285.81 Million SAR | -3.55% |
| 2015 Q4 | 299.89 Million SAR | 4.93% |
| 2015 FY | 299.89 Million SAR | 128.02% |
| 2015 Q1 | 256.72 Million SAR | 95.19% |
| 2015 Q2 | 296.32 Million SAR | 15.43% |
| 2014 Q2 | 39.1 Million SAR | 196.38% |
| 2014 FY | 131.52 Million SAR | 85.31% |
| 2014 Q1 | -40.57 Million SAR | -157.18% |
| 2014 Q3 | 147.83 Million SAR | 278.0% |
| 2014 Q4 | 131.52 Million SAR | -11.03% |
| 2013 Q1 | -256.55 Million SAR | 53.81% |
| 2013 Q2 | -62.69 Million SAR | 75.56% |
| 2013 Q3 | -56.07 Million SAR | 10.56% |
| 2013 FY | 70.97 Million SAR | 112.78% |
| 2013 Q4 | 70.97 Million SAR | 226.56% |
| 2012 FY | -555.44 Million SAR | -14477.84% |
| 2012 Q4 | -555.44 Million SAR | -1469.21% |
| 2012 Q3 | -35.39 Million SAR | 0.0% |
| 2011 FY | -3.81 Million SAR | 0.0% |
| 2011 Q4 | -3.81 Million SAR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Mouwasat Medical Services Company | 739.42 Million SAR | -135.057% |
| National Medical Care Company | 21.57 Million SAR | -7955.049% |
| Al Hammadi Company For Development and Investment | 188.91 Million SAR | -820.056% |
| Middle East Healthcare Company | 2.44 Billion SAR | 28.791% |
| Dr. Sulaiman Al Habib Medical Services Group Company | 2.56 Billion SAR | 32.187% |
| Canadian General Medical Center Complex Company | 1.2 Million SAR | -143720.952% |
| Arabian International Healthcare Holding Company | 427.83 Million SAR | -306.251% |
| Future Care Trading Co. | -48.69 Million SAR | 3669.014% |
| Naba Alsaha Medical Services Company | 42.44 Million SAR | -3994.715% |
| Lana Medical Co. | -8.28 Million SAR | 21070.7% |
| Al-Modawat Specialized Medical Co. | 2.49 Million SAR | -69494.4% |